Bevasiranib - CAS 959961-96-7

Bevasiranib, a siRNA, is specifically engineered to suppress the expression of genes responsible for the production of vascular endothelial growth factor (VEGF), a critical factor in the development of choroidal neo-vascularization (CNV), which precedes wet age-related macular degeneration (wet AMD) .

Others, VEGFR

Tyrosine Kinase/Adaptors, Others, Angiogenesis

959858

-20°C

Ice Packs

Small Compound